4.7 Review

A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Insights into peptidylarginine deiminase expression and citrullination pathways

Karen Yu et al.

Summary: This article provides a comprehensive overview of PAD enzyme expression at the RNA and protein levels, as well as a list of annotated substrates for each PAD isozyme. The authors discuss novel roles of citrullination in cellular growth, epigenetic regulation, tissue remodeling, inflammation, and cancer in mouse models and humans. Additionally, they cluster similar effects of protein deimination to provide a different perspective and improve understanding of citrullination in health and disease.

TRENDS IN CELL BIOLOGY (2022)

Article Medicine, Research & Experimental

Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases

Ilya Korsunsky et al.

Summary: This study provides a comprehensive investigation into fibroblasts across different diseases, identifying shared pathogenic activation states and two common types of pro-inflammatory fibroblasts.
Article Rheumatology

Synergistic Roles of Macrophages and Neutrophils in Osteoarthritis Progression

Ming-Feng Hsueh et al.

Summary: The study evaluated the role of immune cells and cytokines in the pathogenesis and progression of knee osteoarthritis. The results showed that concentrations of elastase and TGF-beta 1 in SF were associated with the severity of OA progression, indicating their predictive potential for disease progression.

ARTHRITIS & RHEUMATOLOGY (2021)

Review Rheumatology

Axial spondyloarthritis: concept, construct, classification and implications for therapy

Philip C. Robinson et al.

Summary: The concept of axial spondyloarthritis (axSpA) has evolved significantly since the definition of ankylosing spondylitis in 1984, from solely erosions in the sacroiliac joints to a spectrum of disease with or without visible changes on plain radiographs. The use of MRI has greatly impacted the diagnosis and classification of axSpA, yet there is still controversy surrounding the specificity of current classification criteria.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Rheumatology

Reactive arthritis and undifferentiated peripheral spondyloarthritis share human leucocyte antigen B27 subtypes and serum and synovial fluid cytokine profiles

Jyoti Ranjan Parida et al.

Summary: Reactive arthritis (ReA) and undifferentiated peripheral SpA (upSpA) share similarities in HLA-B27 subtype associations and cytokine profiles, suggesting they should be considered as a single entity for research and clinical management.

RHEUMATOLOGY (2021)

Article Medical Laboratory Technology

Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis

Shin Eui Kang et al.

Summary: The study generated a novel BsAb targeting both TNF-alpha and CXCL10, showing efficacy in inhibiting inflammation and bone destruction in RA models, suggesting a new therapeutic opportunity for RA patients who do not respond to single cytokine blockade.

TRANSLATIONAL RESEARCH (2021)

Review Biochemistry & Molecular Biology

Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms

Beatrice Maranini et al.

Summary: Adult-onset Still's disease is a systemic inflammatory disease with unknown etiology, characterized by a cytokine storm. A portion of patients with severe symptoms, known as refractory AOSD patients, are resistant to standard treatments and may require higher dosages of glucocorticoids and immunosuppressive drugs. Analysis of literature data aims to identify biomarkers that could guide clinical decisions and lead to new therapeutic options.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Type 1 helper T cells generate CXCL9/10-producing T-bet+ effector B cells potentially involved in the pathogenesis of rheumatoid arthritis

Tsuyoshi Nakayama et al.

Summary: The efficacy of B-cell depletion therapy in rheumatoid arthritis highlights the antibody-independent effector functions of B cells. Studies have shown that Th1 cells can promote the generation of CXCL9/10-producing T-bet+ B cells in RA, suggesting a potential novel target for therapy.

CELLULAR IMMUNOLOGY (2021)

Review Rheumatology

Targeting interferon-γ in hyperinflammation: opportunities and challenges

Fabrizio De Benedetti et al.

Summary: Interferon-gamma (IFN gamma) plays a crucial role in immune responses and its overproduction is associated with hyperinflammation. Research has identified relevant biomarkers related to IFN gamma and shown promising results of IFN gamma-neutralizing agents in the treatment of specific diseases.

NATURE REVIEWS RHEUMATOLOGY (2021)

Review Medicine, General & Internal

Diagnosis and Treatment of Hip and Knee Osteoarthritis A Review

Jeffrey N. Katz et al.

Summary: Osteoarthritis is a prevalent joint disease that can impact various joints, with risk factors including age, gender, obesity, genetics, and major joint injury. Treatment typically involves exercise, weight management, education, and medication therapy. Advanced cases may require surgical intervention for pain relief and improved function.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Pediatrics

Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study

Heshuang Qu et al.

Summary: This study identified a novel set of biomarkers that distinguish active sJIA from inactive sJIA or healthy controls, enabling a better understanding of the immune mechanisms at play in sJIA and aiding in the development of future diagnostic and therapeutic strategies.

PEDIATRIC RHEUMATOLOGY (2021)

Article Rheumatology

A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis

Tanja Hinze et al.

Summary: In patients with SJIA treated with canakinumab, baseline serum biomarkers such as IL-18 and IFN-gamma levels are associated with treatment outcome. Higher IL-18: CXCL9 and IFN-gamma: CXCL9 ratios at baseline are correlated with a better clinical response to canakinumab treatment. Further studies are needed to validate these findings and their applicability to patients with recent MAS.

RHEUMATOLOGY (2021)

Article Immunology

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8

Mieke Metzemaekers et al.

Summary: This study introduces a novel methodology (ISTAMPA) that combines immunoaffinity sample preparation with nano-scale liquid chromatography-tandem mass spectrometry for proteoform analysis. The research demonstrates the presence of different NH2-terminal proteoforms of CXCL8 due to site-specific proteolytic modification, with specific proteoforms showing enhanced activity. An immunosorbent ion trap top-down mass spectrometry-based approach allows for simultaneous detection and quantification of full-length CXCL8(1-77), elongated CXCL8(-2-77) and all naturally occurring truncated CXCL8 forms in biological samples.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6

Andy Chevigne et al.

Summary: In this study, the atypical chemokine receptor ACKR2 was found to reduce the availability of the CXC chemokine CXCL10 for CXCR3, shedding new light on the complexity of the chemokine network and the potential role of CXCL10 regulation by ACKR2 in tumor immunology. This discovery highlights the importance of systematically reassessing chemokine-receptor interactions, as important interactions may remain unexplored.

CANCERS (2021)

Review Rheumatology

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Daniele Mauro et al.

Summary: Ankylosing spondylitis (AS) is a chronic inflammatory disease with features of both autoimmune and autoinflammatory processes. While the innate immune system plays a dominant role in AS, factors such as the intestine and biomechanical elements may also contribute to the disease's pathogenesis. Studies suggest a combination of autoinflammation and autoimmunity in AS, with evidence supporting both hypotheses.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Rheumatology

Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions

Sabine Arve-Butler et al.

Summary: Neutrophils in the synovial fluid of children with oligoarticular juvenile idiopathic arthritis (JIA) exhibit an altered phenotype and function, characterized by activation, an aged phenotype, monocyte-like features, and impaired phagocytic capacity. The presence of CD206-expressing neutrophils in the synovial fluid and tissue suggests a potential role in disease pathogenesis. These alterations in neutrophils may contribute to sustained joint inflammation in JIA.

ARTHRITIS RESEARCH & THERAPY (2021)

Review Rheumatology

The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review

Khalid Almutairi et al.

Summary: The study aimed to determine the global population prevalence of rheumatoid arthritis (RA) from 1980 to 2019 and found a global RA prevalence estimate of 0.46%, with variations due to geographical location and study methodology. The highest RA prevalence (0.69%) was derived from studies involving linked data sources.

RHEUMATOLOGY INTERNATIONAL (2021)

Article Immunology

Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults

Stephen McBride et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Orthopedics

Osteoarthritic Milieu Affects Adipose-Derived Mesenchymal Stromal Cells

Cristina Manferdini et al.

JOURNAL OF ORTHOPAEDIC RESEARCH (2020)

Article Immunology

Canakinumab for the treatment of adult-onset Still's disease

Paolo Sfriso et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)

Review Immunology

Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation

Helena Crijns et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Medical Laboratory Technology

Increased FURIN expression in rheumatoid arthritis patients and its anti-inflammatory effect

Rong Cao et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Review Immunology

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside

Mohamed A. Alfaleh et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

Pathogenic, glycolytic PD-1+ cells accumulate in the hypoxic RA joint

Achilleas Floudas et al.

JCI INSIGHT (2020)

Review Rheumatology

Peripheral spondyloarthritis: a neglected entity-state of the art

Philippe Carron et al.

RMD OPEN (2020)

Review Immunology

Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis

Noha Mousaad Elemam et al.

IMMUNOTARGETS AND THERAPY (2020)

Article Infectious Diseases

First description of agonist and antagonist IP-10 in urine of patients with active TB

Linda Petrone et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)

Article Immunology

Pathogen Evasion of Chemokine Response Through Suppression o CXCL10

Alejandro L. Antonia et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Article Rheumatology

Anakinra in children and adults with Still's disease

Sebastiaan J. Vastert et al.

RHEUMATOLOGY (2019)

Article Rheumatology

Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis

A. Valli et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2019)

Review Emergency Medicine

Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department

Brit Long et al.

WESTERN JOURNAL OF EMERGENCY MEDICINE (2019)

Review Cell & Tissue Engineering

Ankylosing spondylitis: etiology, pathogenesis, and treatments

Wei Zhu et al.

BONE RESEARCH (2019)

Review Immunology

Chemokines in homeostasis and diseases

Keqiang Chen et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Review Rheumatology

Epidemiology of axial spondyloarthritis: an update

Runsheng Wang et al.

CURRENT OPINION IN RHEUMATOLOGY (2018)

Article Pharmacology & Pharmacy

JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model

Bongjun Kim et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

Review Rheumatology

New Markers for Adult-Onset Still's Disease

Stephane Mitrovic et al.

JOINT BONE SPINE (2018)

Review Medicine, General & Internal

Psoriatic arthritis 1 The pathogenesis of psoriatic arthritis

Douglas J. Veale et al.

LANCET (2018)

Article Biochemistry & Molecular Biology

Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney

Madalina Viviana Nastase et al.

MATRIX BIOLOGY (2018)

Review Rheumatology

Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis

Lorenza Scotti et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)

Review Immunology

A comprehensive review on adult onset Still's disease

Roberto Giacomelli et al.

JOURNAL OF AUTOIMMUNITY (2018)

Article Biochemistry & Molecular Biology

Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation

Jeffrey S. Smith et al.

SCIENCE SIGNALING (2018)

Review Medicine, General & Internal

The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer

Paula T. Kuo et al.

FRONTIERS IN MEDICINE (2018)

Review Immunology

A fresh look at angiogenesis in juvenile idiopathic arthritis

Joanna Swidrowska-Jaros et al.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2018)

Review Pharmacology & Pharmacy

Designing small molecule CXCR3 antagonists

James E. Pease

EXPERT OPINION ON DRUG DISCOVERY (2017)

Article Immunology

Septic Arthritis of Native Joints

John J. Ross

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)

Review Immunology

Chemokine isoforms and processing in inflammation and immunity

Paul Proost et al.

JOURNAL OF AUTOIMMUNITY (2017)

Article Rheumatology

Elevated ACKR2 expression is a common feature of inflammatory arthropathies

Helen M. Baldwin et al.

RHEUMATOLOGY (2017)

Article Biochemistry & Molecular Biology

Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization

Douglas P. Dyer et al.

OPEN BIOLOGY (2017)

Review Biochemistry & Molecular Biology

Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation

Jin Hee Park et al.

MOLECULES AND CELLS (2017)

Article Rheumatology

Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker

Jayesh M. Pandya et al.

ARTHRITIS RESEARCH & THERAPY (2017)

Article Biochemistry & Molecular Biology

NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells

Won Jong Jin et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2017)

Article Biochemistry & Molecular Biology

The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization

Douglas P. Dyer et al.

GLYCOBIOLOGY (2016)

Article Chemistry, Medicinal

Small Molecule CXCR3 Antagonists

Stephen P. Andrews et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Rheumatology

Successes and failures of chemokine-pathway targeting in rheumatoid arthritis

Zoltan Szekanecz et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Article Biochemistry & Molecular Biology

Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis

Jianing Wang et al.

CYTOKINE (2016)

Review Medicine, General & Internal

Rheumatoid arthritis

Josef S. Smolen et al.

LANCET (2016)

Review Biochemistry & Molecular Biology

Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases

Ghislain Opdenakker et al.

TRENDS IN MOLECULAR MEDICINE (2016)

Article Multidisciplinary Sciences

Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone

Bin Huang et al.

NATURE COMMUNICATIONS (2016)

Article Medicine, General & Internal

Osteoarthritis

Johanne Martel-Pelletier et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Pharmacology & Pharmacy

CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways

Yamina A. Berchiche et al.

MOLECULAR PHARMACOLOGY (2016)

Review Medicine, General & Internal

Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options

Sabeeda Kadavath et al.

ANNALS OF MEDICINE (2015)

Article Pharmacology & Pharmacy

CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779

Belinda Nedjai et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

Review Biochemistry & Molecular Biology

CXCR3 ligands in disease and therapy

Katrien Van Raemdonck et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2015)

Article Biochemistry & Molecular Biology

Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages

Juan Wang et al.

FASEB JOURNAL (2015)

Article Biochemistry & Molecular Biology

Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines

Urska Repnik et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Letter Dermatology

Gene Expression Differences between Psoriasis Patients with and without Inflammatory Arthritis

Remy A. Pollock et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Review Rheumatology

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

Josef S. Smolen et al.

NATURE REVIEWS RHEUMATOLOGY (2015)

Article Orthopedics

Using diet-induced obesity to understand a metabolic subtype of osteoarthritis in rats

K. H. Collins et al.

OSTEOARTHRITIS AND CARTILAGE (2015)

Article Immunology

Circulating levels of chemokines in psoriasis

Xinaida Taligare Lima et al.

AUTOIMMUNITY (2015)

Article Biochemistry & Molecular Biology

Boronic Acids as Probes for Investigation of Allosteric Modulation of the Chemokine Receptor CXCR3

Viachaslau Bernat et al.

ACS CHEMICAL BIOLOGY (2014)

Review Immunology

Adult-onset Still's disease

Mathieu Gerfaud-Valentin et al.

AUTOIMMUNITY REVIEWS (2014)

Article Chemistry, Medicinal

IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: Improved PK, hERG and metabolic profiles

Anilkumar G. Nair et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

Article Developmental Biology

Chemokine signaling in development and disease

John Wang et al.

DEVELOPMENT (2014)

Review Rheumatology

Advances in the management of psoriatic arthritis

Ignazio Olivieri et al.

NATURE REVIEWS RHEUMATOLOGY (2014)

Article Rheumatology

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

Glynn Dennis et al.

ARTHRITIS RESEARCH & THERAPY (2014)

Article Critical Care Medicine

CXCL10-CXCR3 Enhances the Development of Neutrophil-mediated Fulminant Lung Injury of Viral and Nonviral Origin

Akihiko Ichikawa et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Review Immunology

The interaction between CXCL10 and cytokines in chronic inflammatory arthritis

Eun Young Lee et al.

AUTOIMMUNITY REVIEWS (2013)

Review Cell Biology

In vivo regulation of chemokine activity by post-translational modification

Eva A. V. Moelants et al.

IMMUNOLOGY AND CELL BIOLOGY (2013)

Review Rheumatology

Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors

Nunzio Bottini et al.

NATURE REVIEWS RHEUMATOLOGY (2013)

Review Immunology

Interleukin-18, more than a Th1 cytokine

Daniela Novick et al.

SEMINARS IN IMMUNOLOGY (2013)

Review Medicine, Research & Experimental

Familial and Acquired Hemophagocytic Lymphohistiocytosis

G. E. Janka

ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)

Article Immunology

Discrimination of agonist and antagonist forms of CXCL10 in biological samples

A. Casrouge et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)

Review Immunology

The Chemokine Superfamily Revisited

Albert Zlotnik et al.

IMMUNITY (2012)

Article Multidisciplinary Sciences

Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation

Graeme O'Boyle et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Rheumatology

Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and Focal

Chad Deal

CURRENT RHEUMATOLOGY REPORTS (2012)

Article Rheumatology

Local Expression of Interleukin-27 Ameliorates Collagen-Induced Arthritis

Sarah R. Pickens et al.

ARTHRITIS AND RHEUMATISM (2011)

Article Chemistry, Medicinal

III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold

Seong Heon Kim et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Hematology

How I treat hemophagocytic lymphohistiocytosis

Michael B. Jordan et al.

Review Oncology

Chemokines as mediators of tumor angiogenesis and neovascularization

Ellen C. Keeley et al.

EXPERIMENTAL CELL RESEARCH (2011)

Review Oncology

Effect of posttranslational processing on the in vitro and in vivo activity of chemokines

Anneleen Mortier et al.

EXPERIMENTAL CELL RESEARCH (2011)

Article Rheumatology

Inflammatory Musculoskeletal Disease: Identification and Assessment

PHILIP J. MEASE

JOURNAL OF RHEUMATOLOGY (2011)

Article Medicine, General & Internal

Juvenile idiopathic arthritis

Berent Prakken et al.

LANCET (2011)

Review Rheumatology

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

Elizabeth D. Mellins et al.

NATURE REVIEWS RHEUMATOLOGY (2011)

Article Immunology

Overcoming hurdles in developing successful drugs targeting chemokine receptors

Thomas J. Schall et al.

NATURE REVIEWS IMMUNOLOGY (2011)

Article Rheumatology

Up-Regulation of Cytokines and Chemokines Predates the Onset of Rheumatoid Arthritis

Heidi Kokkonen et al.

ARTHRITIS AND RHEUMATISM (2010)

Article Rheumatology

Pathogenic Role of CXCR7 in Rheumatoid Arthritis

Kaori Watanabe et al.

ARTHRITIS AND RHEUMATISM (2010)

Article Chemistry, Medicinal

Discovery of a novel series of CXCR3 antagonists

Stefano Crosignani et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Immunology

Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue

E. D. SILVERMAN et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

Review Biochemistry & Molecular Biology

Gene modulation and immunoregulatory roles of Interferonγ

Banishree Saha et al.

CYTOKINE (2010)

Review Immunology

Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis

Beatrix Bartok et al.

IMMUNOLOGICAL REVIEWS (2010)

Article Biochemistry & Molecular Biology

Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans

India C. Severin et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Medicine, Research & Experimental

Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4

Dianhua Jiang et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Multidisciplinary Sciences

CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3

Gabriele S. V. Campanella et al.

PLOS ONE (2010)

Article Rheumatology

Systemic JIA: new developments in the understanding of the pathophysiology and therapy

Sebastiaan J. Vastert et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)

Article Chemistry, Medicinal

Optimization of a series of quinazolinone-derived antagonists of CXCR3

Jiwen Liu et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Chemistry, Medicinal

Imidazo-pyrazine derivatives as potent CXCR3 antagonists

Xiaohui Du et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Cell Biology

CXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 Signaling

Fabienne T. Schulthess et al.

CELL METABOLISM (2009)

Article Medicine, Research & Experimental

Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice

Jana Pachlopnik Schmid et al.

EMBO MOLECULAR MEDICINE (2009)

Article Immunology

CXCR3 Mediates Renal Th1 and Th17 Immune Response in Murine Lupus Nephritis

Oliver M. Steinmetz et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Pharmacology & Pharmacy

Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5

Spencer E. Hall et al.

MOLECULAR PHARMACOLOGY (2009)

Article Biochemistry & Molecular Biology

Reliability of tumor markers, chemokines, and metastasis-related molecules in serum

Faina Linkov et al.

EUROPEAN CYTOKINE NETWORK (2009)

Article Chemistry, Medicinal

Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3

Martin E. Hayes et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

Review Chemistry, Medicinal

Towards small-molecule CXCR3 ligands with clinical potential

Maikel Wijtmans et al.

CHEMMEDCHEM (2008)

Article Cell Biology

CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3

Anja Mueller et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2008)

Review Pharmacology & Pharmacy

Regulation of chemokine activity by posttranslational modification

Anneleen Mortier et al.

PHARMACOLOGY & THERAPEUTICS (2008)

Article Multidisciplinary Sciences

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

Gabriele S. V. Campanella et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Rheumatology

Cia5d regulates a new fibroblast-like synoviocyte invasion-associated gene expression signature

Teresina Laragione et al.

ARTHRITIS RESEARCH & THERAPY (2008)

Article Chemistry, Medicinal

Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists

Robert J. Watson et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Multidisciplinary Sciences

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7

Frederic Sierro et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Chemistry, Medicinal

Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3

Michael Johnson et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Rheumatology

Specific gene expression profiles in systemic juvenile idiopathic arthritis

Emma Mary Ogilvie et al.

ARTHRITIS AND RHEUMATISM (2007)

Article Biochemistry & Molecular Biology

Inhibition of Gαi2 activation by Gαi3 in CXCR3-mediated signaling

Brian D. Thompson et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Chemistry, Medicinal

Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists

Daniel R. Allen et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Rheumatology

High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis

Reuben Gobezie et al.

ARTHRITIS RESEARCH & THERAPY (2007)

Article Immunology

A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury

T. Akahori et al.

TRANSPLANTATION PROCEEDINGS (2006)

Article Immunology

Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity

Gabriele S. V. Campanella et al.

JOURNAL OF IMMUNOLOGY (2006)

Article Biochemistry & Molecular Biology

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries

Ilana L. Stroke et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Medicine, Research & Experimental

TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis

Tamara Loos et al.

LABORATORY INVESTIGATION (2006)

Article Rheumatology

Paediatric rheumatology - A global perspective

S Sawhney et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)

Review Biochemistry & Molecular Biology

Matrix metalloproteinases: Role in arthritis

PS Burrage et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2006)

Review Biochemistry & Molecular Biology

CXC chemokines in angiogenesis

RM Strieter et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2005)

Review Biochemistry & Molecular Biology

Synergy in cytokine and chemokine networks amplifies the inflammatory response

M Gouwy et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2005)

Article Rheumatology

Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis

T Nanki et al.

ARTHRITIS AND RHEUMATISM (2005)

Article Pharmacology & Pharmacy

Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist

CE Heise et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Rheumatology

Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5

C Schmutz et al.

ARTHRITIS RESEARCH & THERAPY (2005)

Article Rheumatology

CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis

G Martini et al.

ARTHRITIS RESEARCH & THERAPY (2005)

Review Immunology

Chemokines: multiple levels of leukocyte migration control

B Moser et al.

TRENDS IN IMMUNOLOGY (2004)

Article Cell Biology

I-TAC/CXCL11 is a natural antagonist for CCR5

V Petkovic et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

Article Biochemistry & Molecular Biology

The human Duffy antigen binds selected inflammatory but not homeostatic chemokines

L Gardner et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Immunology

Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands

N Kohrgruber et al.

JOURNAL OF IMMUNOLOGY (2004)

Article Biochemistry & Molecular Biology

The inflammatory side of human chondrocytes unveiled by antibody microarrays

F De Ceuninck et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Review Multidisciplinary Sciences

Evolving concepts of rheumatoid arthritis

GS Firestein

NATURE (2003)

Article Biochemistry & Molecular Biology

Chemokine/chemokine receptor nomenclature

K Bacon et al.

CYTOKINE (2003)

Review Microbiology

Acute septic arthritis

ME Shirtliff et al.

CLINICAL MICROBIOLOGY REVIEWS (2002)

Article Rheumatology

Long-term outcome in patients with juvenile idiopathic arthritis

K Minden et al.

ARTHRITIS AND RHEUMATISM (2002)

Article Rheumatology

A subset of natural killer cells is greatly expanded within inflamed joints

N Dalbeth et al.

ARTHRITIS AND RHEUMATISM (2002)

Article Pediatrics

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

S Sawhney et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2001)

Article Biochemistry & Molecular Biology

Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts

H Smolian et al.

BIOLOGICAL CHEMISTRY (2001)

Article Biochemistry & Molecular Biology

Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity

PJ Hensbergen et al.

EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)

Article Biochemistry & Molecular Biology

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3

P Loetscher et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Immunology

CXCR3 and CCR5 ligands in rheumatoid arthritis synovium

DD Patel et al.

CLINICAL IMMUNOLOGY (2001)